Procter & Gamble (PG) price target to $58 from $60 at Caris

Ben Zinga

August 25, 2009 9:00am Comments

Caris lowered Procter & Gamble's (NYSE: PG) price target following the Rx drug divestiture. The firm is positive on the move long-term but said it is dilutive near-term. Shares are Buy rated.

View Comments and Join the Discussion!

View the discussion thread.

Posted-In: Downgrades Analyst Ratings

Need analyst data?
Click here to see licensing options.

Latest Ratings

Stock	Firm	Action	PT
SEDG	B of A Securities	Maintains	411.0
PTLO	Piper Sandler	Maintains	28.0
AOUT	Lake Street	Maintains	26.0
RAPT	Piper Sandler	Maintains	52.0
OCX	Lake Street	Maintains	6.0

View the Latest Analytics Ratings

1	MOVE: Movano Evie Ring Could Soon Get FDA Clearance, Analyst Says: 'A Validat...
2	AMKR, ON: Wall Street Rises Ahead Of Big Tech Earnings, Fed Meeting; Tesla Reb...
3	The Secret To Going Viral In The Cannabis Space: How One Creator Is...
4	Jerome Powell Faces Trump Dilemma Over Potential Policy Shocks Amid...
5	IEMG, UNG: Asia Advances, Europe Mixed; Crude Slips To $77 And Gold Su...
6	EXP, AAL: PayPal Posts Upbeat Earnings, Joins Sprouts Farmers...
7	ASPN, RBLX: Roblox to Report Q2 Earnings: What's...

1	Trump Vs. Harris: Vice President Leads 2024 Election By 1 Point, Hits Records Fo...
2	Does Cannabis Affect Your Driving? University Of Colorado Researchers Find Out
3	Israel's Air Strike On Beirut Believed To Have Killed Hezbollah Commander
4	SONY, WBD: Harry Potter: Quidditch Champions Trailer Reveal – Gameplay, Characte...
5	Trump Says Harris Jailed 'Thousands And Thousands Of Black People&...
6	NVDA, AMD: Nvidia Stock Is Surging After The Bell: What's Going On?
7	CZR: Caesars Entertainment Stock Is Up After Q2 Results

Market Overview

Tickers

Articles

Keywords

Procter & Gamble (PG) price target to $58 from $60 at Caris

Related Articles (PG)

Latest Ratings